Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auspex Pharmaceuticals, Inc. (ASPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/28/2015 SC 13D/A Thomas, McNerney & Partners II L.P. has filed a Schedule 13D for Auspex Pharmaceuticals, Inc.
05/14/2015 SC 13G/A Flynn James E reports a 0% stake in Auspex Pharmaceuticals, Inc.
05/05/2015 8-K Form 8-K - Current report
05/05/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/05/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/24/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/24/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/23/2015 10-K/A Annual Report for the period ended December 31, 2014 [amend]
04/20/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/20/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/17/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Auspex Pharmaceuticals, Inc. poster"
04/10/2015 SC 13D INTEGRATED CORE STRATEGIES LLC reports a 5.9% stake in Auspex Pharmaceuticals, Inc.
04/10/2015 SC 13G/A FMR LLC reports a 5.6% stake in AUSPEX PHARMACEUTICALS INC
04/08/2015 SC 13D TEVA PHARMACEUTICAL INDUSTRIES LTD reports a 30% stake in Auspex Pharmaceuticals, Inc.
04/07/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
04/07/2015 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
03/31/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
03/30/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger, by and among Auspex Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Aurum Merger Sub, Inc",
"Form of Tender and Support Agreement, by and among Teva Pharmaceutical Industries Ltd, Aurum Merger Sub, Inc. and the directors and certain stockholders of Auspex Pharmaceuticals, Inc"
03/30/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
03/30/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
03/30/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
03/30/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
03/16/2015 10-K Annual Report for the period ended December 31, 2014
03/16/2015 8-K Quarterly results
Docs: "AUSPEX PHARMACEUTICALS REPORTS FOURTH QUARTER 2014 RESULTS AND BUSINESS HIGHLIGHTS"
02/20/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/13/2015 SC 13D/A Thomas, McNerney & Partners II L.P. reports a 15.9% stake in Auspex Pharmaceuticals, Inc.
02/13/2015 SC 13G/A FMR LLC reports a 14.8% stake in AUSPEX PHARMACEUTICALS INC
02/12/2015 SC 13G Presidio Partners 2007, L.P. reports a 12.8% stake in AUSPEX PHARMACEUTICALS, INC.
01/23/2015 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]
01/21/2015 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/12/2015 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "AUSPEX ANNOUNCES FAVORABLE TOPLINE RESULTS FROM THOROUGH QT CLINICAL TRIAL OF SD-809"
01/07/2015 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933
12/22/2014 SC 13G/A Flynn James E reports a 10.7% stake in Auspex Pharmaceuticals, Inc.
12/16/2014 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Auspex Pharmaceuticals, Inc. Presentation"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy